March 11 – 13, 2024 | Long Beach, California, USA
The 2024 Hybrid US Bioassay Conference is an event organized by the BioPharmaceutical Emerging Best Practices Association (BEBPA), a non-profit organization for the biopharmaceutical scientific community. The conference will feature presentations, workshops and round-table discussions on topics of current interest to the analytical biopharmaceutical field, such as life cycle assay development, biosimilar potency assay development, reference material, and data analysis.
The conference will also include exhibitors from various companies and organizations related to the bioassay industry. The conference aims to provide a platform for industrial scientists to share common technical problems, suggest potential solutions, and discuss the merits of such solutions.
Cencora PharmaLex Speaker Sessions
Pierre Lebrun
Director Statistics
Tuesday, March 12 | 2:25
Location: Centennial Ballroom C
All You Ever Wanted to Know About Target Measurement Uncertainty and Total Analytical Error for Analytical Validation
